colorectal cancer: Patients diagnosed with colorectal cancer by pathological biopsy.
colorectal neoplasm: Patients diagnosed with colorectal adenoma confirmed by colonoscopy.
Study summary
Colorectal cancer is one of the malignant tumours with high morbidity and mortality worldwide, posing a serious threat to human health. In recent years, the incidence of colorectal cancer has been on the rise with changes in lifestyle and dietary habits. Although some progress has been made in treatments such as surgery, chemotherapy and radiotherapy, however, the early diagnosis, prognosis assessment and personalised treatment of colorectal cancer still face great challenges. Therefore, it is of great academic value and practical significance to deeply explore the influencing factors of colorectal cancer occurrence, development and its prognosis, especially the research on environmental factors and metabolomics.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
1. Healthy control group:
* age ≥18 years old;
* no history of malignant tumour;
* willing to participate in this study and sign the informed consent form;
* complete basic data.
2. Gastric cancer group:
* age ≥18 years old;
* patients diagnosed with gastric cancer by pathological biopsy before operation;
* no chemotherapy, radiotherapy, targeted and immunotherapy before enrolment;
* willing to participate in this study and sign the informed consent; complete clinical data.
Exclusion criteria:
* patients with primary malignant tumours other than gastric cancer;
* patients with serious cardiopulmonary insufficiency and other systemic diseases that affect the choice of treatment plan;
* patients who are not suitable for enrolment as assessed by the investigator.
Primary outcome measure(s)
Rate of postoperative complications — From date of surgery until the date of first documented postoperative complication, assessed up to 2 months after surgery. Surgical complications was defined as any postoperative complication occurring during the postoperative hospitalisation period.
Trial sites (1)
Facility
City
Region
Status
the First Affiliated Hospital of Chongqing Medical University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.